1. "Thoracic Oncology"
Formats
  1. Meeting Abstract (1694)
  2. Journal Article (1416)
  3. Review (80)
  4. Editorial (56)
  5. Book Section (35)
  6. Guidelines (24)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3351)
  2. Solid Tumor Oncology Division (3351)
  3. Thoracic Oncology (3351)
  4. GSK Faculty (1056)
  5. Department of Pathology and Laboratory Medicine (797)
  6. Human Oncology and Pathogenesis Program (625)

More Groups

People
  1. Mark Kris (869)
  2. Alexander Drilon (631)
  3. Gregory Riely (599)
  4. Charles Rudin (488)
  5. Marc Ladanyi (414)
  6. Matthew Hellmann (411)

More People

Years
  1. 2025 (73)
  2. 2024 (270)
  3. 2023 (272)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (692)
  2. Journal of Thoracic Oncology (513)
  3. Annals of Oncology (277)
  4. Clinical Cancer Research (156)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (769)
  2. Elsevier Inc. (734)
  3. American Association for Cancer Research (383)
  4. Oxford University Press (350)
  5. Nature Publishing Group (148)
  6. Elsevier Science, Inc. (78)

More Publishers

Results (3351)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeted cancer genome sequencing in thymic epithelial tumors
    Meeting Abstract

    Moreira, A.; McMillan, R.; Won, H.; Huang, J.; Riely, G.; Ladanyi, M.; Berger, M.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Feedback dependent suppression of mitogenic signaling and its effect on RAF inhibition in BRAFV600E melanomas
    Meeting Abstract

    Lito, P.; Pratilas, C.; Joseph, E.; Tadi, M.; Halilovic, E.; Zubrowski, M.; Huang, A.; de Stanchina, E.; Chandarlapaty, S.; Poulikakos, P.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Feasibility of long-term patient self-reporting of toxicities from home via the internet during routine chemotherapy
    Journal Article

    Judson, T. J.; Bennett, A. V.; Rogak, L. J.; Sit, L.; Barz, A.; Kris, M. G.; Hudis, C. A.; Scher, H. I.; Sabbatini, P.; Schrag, D.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Anaplastic lymphoma kinase (ALK) positive central nervous system (CNS) metastases from non small cell lung cancer (NSCLC)
    Meeting Abstract

    Singer, S.; Riely, G. J.; Kris, M. G.; Grommes, C.
    Neuro-Oncology (2013)

    Fulltext@MSK | Save
  • Systemic bevacizumab (Bev) for leptomeningeal disease (LMD) from non-small cell lung cancer
    Meeting Abstract

    Carlo, M.; Omuro, A.; Grommes, C.; Kris, M.; Nolan, C.; Pentsova, E.; Pietanza, M.; Kaley, T.
    Neuro-Oncology (2013)

    Fulltext@MSK | Save
  • Crizotinib vs. pemetrexed or docetaxel in advanced ALK+ non-small cell lung cancer: Subgroup analysis in PROFILE 1007
    Meeting Abstract

    Yamamoto, N.; Nokihara, H.; Han, J. Y.; Hida, T.; Riely, G. J.; Baldini, E.; Salvatore, S.; Horn, L.; Polli, A.; Satouchi, M.
    Annals of Oncology (2013)

    Fulltext@MSK | Save
  • Crizotinib treatment in patients (pts) with advanced ROS1-rearranged non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Ou, S. H. I.; Kim, D. W.; Camidge, R.; Riely, G. J.; Salgia, R.; Shapiro, G.; Clark, J. W.; Tye, L.; Iafrate, A. J.; Shaw, A.
    Annals of Oncology (2013)

    Fulltext@MSK | Save
  • Clinical experience with crizotinib in patients (pts) with advanced ALK plus non-small cell lung cancer (NSCLC) and brain metastases
    Meeting Abstract

    Crino, L.; Ahn, M. J.; Ou, S. H. I.; Solomon, B. J.; Costa, D. B.; Shreeve, S. M.; Wiltshire, R.; Selaru, P.; Zhou, C.; Riely, G. J.
    European Journal of Cancer (2013)

    Fulltext@MSK | Save
  • Structural, biochemical, and clinical characterization of epidermal growth factor receptor (EGFR) exon 20 insertion mutations in lung cancer
    Journal Article

    Yasuda, H.; Park, E.; Yun, C. H.; Sng, N. J.; Lucena-Araujo, A. R.; Yeo, W. L.; Huberman, M. S.; Cohen, D. W.; Nakayama, S.; Ishioka, K.; more...
    Science Translational Medicine (2013)

    Fulltext@MSK | Save
  • Targeted therapies: Afatinib-new therapy option for EGFR-mutant lung cancer
    Journal Article

    Yu, H. A.; Pao, W.
    Nature Reviews Clinical Oncology (2013)

    Fulltext@MSK | Save